[Newsletter] ELK Biotechnology March 2025 Literature Hights: 40+High score recommend_ELK BIOTECHNOLOGY - 코아사이언스

 

ELK Biotechnology March 2025 Literature Hights: 40+High score recommend

In the first quarter of 2025, ELK Biotechnology collected a total of 186 papers. Among them, the highest three papers scored 48.8, 44.8 and 40.8 points respectively. We have to thank the scientific research users for their high recognition of the quality of our ELISA kits. Thank you for your continued support and love for us! Let us appreciate everyone's wonderful research results together~

 

This sharing mainly includes 19 high-scoring literature abstracts that cited articles published by ELK Biotechnology in journals such as Cancer Cell, Science, Nature, Signal Transduction and Targeted Therapy, Nature Biotechnology, and European Heart Journal Open, among which 3 papers with IF exceeding 40.

 

Featured Articles

Citing ELK Products 

Item No.: ELK6778

Nanme: Mouse SFRP2(Secreted Frizzled Related Protein 2) ELISA Kit

 

Title: PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy

Journal: Cancer Cell

Impact factor: 48.8

Author unit: Department of Radiation Oncology, Nanfang Hospital, Southern Medical University

DOI link: https://doi.org/10.1016/j.ccell.2025.02.024

 

Citing ELK Products 

Item No.: ELK0846

Nanme: Human Malonyl CoA (Malonyl Coenzyme A) ELISA Kit

 

Item No.: ELK8137

Nanme: DHA(Docosahexaenoic Acid) ELISA Kit

 

Title: Direct sensing of dietary ω-6 linoleic acid through FABP5-mTORC1 signaling

Journal: SCIENCE

Impact factor: 44.8

Author unit: Department of Pharmacology, Weill Cornell Medical College, New York, NY, USA

DOI link: https://doi.org/10.1126/science.adm9805

 

Citing ELK Products 

Item No.: ELK1921

Nanme: Mouse ALT(Alanine Aminotransferase) ELISA Kit

 

Item No.: ELK1778

Nanme: Mouse AST(Aspartate Aminotransferase) ELISA Kit

 

Title: Photodynamic gel-bombs enhance tumor penetration and downstream synergistic therapies

Journal: Signal Transduction and Targeted Therapy

Impact Factor: 40.8

Author unit: School of Forensic Medicine, Southern Medical University

DOI Link: https://doi.org/10.1038/s41392-025-02186-y

 

코아사이언스 coresciences Korea ELK Biotechnology CO.,LTD ELK (Wuhan) Biotechnology CO.,Ltd. 한국 대리점 ELISA antibody 항체 면역학 연구 세포배양 분자생물학 시약